{"title":"The Cambridge model: how public oversight of biotech is good for everyone--even business.","authors":"Sam Lipson","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":81314,"journal":{"name":"Genewatch : a bulletin of the Committee for Responsible Genetics","volume":"16 5","pages":"7-10"},"PeriodicalIF":0.0000,"publicationDate":"2003-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genewatch : a bulletin of the Committee for Responsible Genetics","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}